Shares of the personal care company are in focus as the company prepares to report its fiscal fourth quarter results on Tuesday. Wall Street expects Kimberly Clark (KMB) to report earnings of $1.42 a share on revenue of about $4.6 billion. For the full year, analysts anticipate earnings of $6 a share on revenue of $18.2 billion. Barclays analysts say they will be watching the company's recovery in developing and emerging markets, which total about 30% of Kimberly Clark's sales. Also on analysts' radar is a slowdown in North American personal care and consumer tissue, totaling about 35% of sales, which could affect revenue growth in 2017.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.